T. Vassilakopoulos Et Al. , "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.140, United States Of America, pp.9554-9556, 2022
Vassilakopoulos, T. Et Al. 2022. Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era. 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (United States Of America), 9554-9556.
Vassilakopoulos, T., Panitsas, F., Mellios, Z., Apostolidis, J., Piperidou, A., Michael, M., ... Gurion, R.(2022). Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era . 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) (pp.9554-9556). , United States Of America
Vassilakopoulos, Theodoros Et Al. "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), United States Of America, 2022
Vassilakopoulos, Theodoros Et Al. "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , United States Of America, pp.9554-9556, 2022
Vassilakopoulos, T. Et Al. (2022) . "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , United States Of America, pp.9554-9556.
@conferencepaper{conferencepaper, author={Theodoros Vassilakopoulos Et Al. }, title={Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era}, congress name={64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={}, country={United States Of America}, year={2022}, pages={9554-9556} }